Fentanyl Detection Devices To Be Distributed in Los Angeles
Defense Diagnostics Inc. (DDI) partners with LA County Supervisor Janice Hahn to distribute DEFENT ONE fentanyl detection devices.
Category: Urinalysis & Toxicology
Urinalysis & Toxicology
Latest
Urinalysis & Toxicology
Latest
New Non-Invasive Biosensor Aids Early Kidney Disease Detection
A novel biosensor detects SDMA in urine, providing a more accurate, non-invasive method for early kidney disease diagnosis and monitoring.
Urinalysis & Toxicology
Latest
Luxor Scientific Unveils Testing Solutions to Combat Illicit Drug Crisis
Luxor Scientific has developed advanced testing solutions to address the nation's ongoing overdose crises.
New Screening Technique Rapidly Detects Drugs in Urine
The new drug screening technique can rapidly detect the presence of 40 forensically relevant drugs from urine samples.
Read More
Keystone Lab Announces Addition of Tianeptine to Testing Menu
Tianeptine is often described as “gas-station dope” and products containing tianeptine commonly use the street names of “ZaZa” or “Tianna.”
Read More
UTI Test Delivers Accuracy, Sustainability, and Flexibility
PathogenDx’s UTI test is built on its D3 Array Platform. The multiplex test has a quick turnaround time with less waste.
Read More
Quest Diagnostics Launches 88-Compound Novel Psychoactive Substance Test Panel
The new panel from Quest tests for 88 compounds, and covers a broad array of drug classes, and other illicit additives.
Read More
New Forensic Toxicology Tech for the Detection of Drugs of Abuse
This product design aims to transform workflows, expediting results for labs tasked to provide care for victims of drug-facilitated crimes.
Read More
Urine Biomarkers Can Outperform Serum Biomarkers in Certain Diseases
Researchers reported the enhanced performance of urinary biomarkers compared to plasma biomarkers for disease detection.
Read More
Fentanyl POC Test Instrument Gets FDA Clearance
Shenzhen Superbio Technology received FDA clearance for a point-of-care instrument intended for the detection of fentanyl in human urine.
Read More
Xylazine Testing Added to NC Lab’s In-House Menu
Keystone Lab has officially added xylazine to its in-house urine clinical toxicology menu.
Read More
Combination Fentanyl and Xylazine Test Strip to Combat Opioid Deaths
HarmGuard FX is a single, low-cost test strip that provides an affordable, reliable way for people to test for fentanyl and xylazine.
Read More
Colli-Pee Self-Sampling Device Could Improve HPV Screening Access
Self-sampling with the Colli-Pee device could significantly expand access to cervical cancer screening for underserved and rural populations.
Read More
Fingerprinting Drug Screening System to Be Used for Fentanyl Testing
Intelligent Bio Solutions Inc. has announced plans to add fentanyl to the substances detected by its Fingerprinting Drug Screening System.
Read More
EarlyTect BCD a Breakthrough Device for Bladder Cancer Detection
FDA has granted Breakthrough Device Designation to EarlyTect BCD as a non-invasive, urine-based diagnostic for bladder cancer in patients with hematuria.
Read More
Xylazine Testing Launched at Philadelphia Lab
Parkway Clinical Laboratories Inc. (PCL), has launched Xylazine testing via LCMSMS confirmation testing on urine specimens.
Read More
Clinisys Acquires Promium to Expand Diagnostics Capabilities
Clinisys has acquired Promium, a provider of laboratory information management systems for environmental analytical testing laboratories.
Read More
Genomic Urine Test Detects Bladder Cancer 12 Years Before Symptoms Appear
This genomic urine test uses next-generation DNA sequencing and machine learning to analyze urine for mutations across 60 genes linked to bladder cancer while also measuring the entire genome.
Read More